%0 Journal Article
%T Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
%A Keunyoung Kim
%A Seong-Jang Kim
%J Archive of "Nuclear Medicine and Molecular Imaging".
%D 2018
%R 10.1007/s13139-017-0505-6
%X Structures and chelators of PRRT for radiolabeling based on octapeptides such as octreotide (a), octreotate (b), DOTA-TOC (c), DOTA-TATE (d), and Lu-177-DOTA-TATE (e). According to the structure of Lu-177-labeled DOTA-TATE, DOTA is a chelator for the coupling of the Lu-177 and the somatostatin analogue (e
%K Peptide receptor radionuclide therapy
%K Neuroendocrine tumors
%K Radiolabeled somatostatin analogues
%K Lu-177
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995779/